Hence, the treatment of MSCs, a component of the osteosarcoma microenvironment, with leptin, a regulator of osteoblastogenesis characteristic of metastasis in bone cancer, stimulated autophagy and activated TGF-β signaling that corresponded to cisplatin resistance in osteosarcoma cells [124]. This evidence concerns the gene LEP and osteosarcoma.